NasdaqCM:TMDI

Stock Analysis Report

Executive Summary

Titan Medical Inc., a research and development stage company, focuses on the design, development, and commercialization of computer-assisted robotic surgical technologies for application in minimally invasive surgery (MIS).

Snowflake

Fundamentals

Worrying balance sheet with weak fundamentals.


Similar Companies

Share Price & News

How has Titan Medical's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

3.9%

NasdaqCM:TMDI

0.5%

US Medical Equipment

-0.02%

US Market


1 Year Return

-5.3%

NasdaqCM:TMDI

9.9%

US Medical Equipment

1.6%

US Market

TMDI underperformed the Medical Equipment industry which returned 9.7% over the past year.

TMDI underperformed the Market in United States of America which returned 1.9% over the past year.


Share holder returns

TMDIIndustryMarket
7 Day3.9%0.5%-0.02%
30 Day-7.8%0.09%2.7%
90 Day-5.3%2.0%1.4%
1 Year-5.3%-5.3%10.8%9.9%3.8%1.6%
3 Year-78.6%-78.6%69.0%63.9%45.2%35.8%
5 Year-96.7%-96.7%136.2%109.3%61.8%44.1%

Price Volatility Vs. Market

How volatile is Titan Medical's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Titan Medical undervalued based on future cash flows and its price relative to the stock market?


In this section, we usually try to help investors determine whether Titan Medical is trading at an attractive price based on the cash flow it is expected to produce in the future. But as Titan Medical has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.


Next Steps

Future Growth

How is Titan Medical expected to perform in the next 1 to 3 years based on estimates from 3 analysts?

11.1%

Forecasted annual earnings growth


Earnings and Revenue Growth Estimates


Future Annual Growth Analysis

Unable to determine if Titan Medical is high growth as no revenue estimate data is available.

Titan Medical is not considered high growth as it is expected to be loss making for the next 1-3 years.

Unable to compare Titan Medical's revenue growth to the United States of America market average as no estimate data is available.

Unable to compare Titan Medical's earnings growth to the United States of America market average as it is expected to be loss making during the next 1-3 years.

Unable to compare Titan Medical's earnings growth to the low risk savings rate as it is expected to be loss making during the next 1-3 years.


Earnings per Share Growth Estimates


Future Return on Equity

Unable to establish if Titan Medical will efficiently use shareholders’ funds in the future without estimates of Return on Equity.


Next Steps

Past Performance

How has Titan Medical performed over the past 5 years?

-14.2%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Titan Medical does not make a profit and their year on year earnings growth rate was negative over the past 5 years.

Unable to compare Titan Medical's 1-year earnings growth to the 5-year average as it is not currently profitable.

Unable to compare Titan Medical's 1-year growth to the US Medical Equipment industry average as it is not currently profitable.


Return on Equity

It is difficult to establish if Titan Medical has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) due to its liabilities exceeding its assets.


Return on Assets

It is difficult to establish if Titan Medical has efficiently used its assets last year compared to the US Medical Equipment industry average (Return on Assets) as it is loss-making.


Return on Capital Employed

It is difficult to establish if Titan Medical improved its use of capital last year versus 3 years ago (Return on Capital Employed) due to its liabilities exceeding its assets.


Next Steps

Financial Health

How is Titan Medical's financial position?


Financial Position Analysis

Titan Medical's short term (1 year) commitments are greater than its holdings of cash and other short term assets.

Titan Medical has no long term commitments.


Debt to Equity History and Analysis

Titan Medical has negative shareholder equity (liabilities exceed assets), this is a more serious situation compared with a high debt level.

Irrelevant to check if Titan Medical's debt level has increased considering it has negative shareholder equity.


Balance Sheet

Low level of unsold assets.

Titan Medical has negative shareholder equity (liabilities exceed assets) therefore debt is not covered by short term assets.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Titan Medical has less than a year of cash runway based on current free cash flow.

Titan Medical has less than a year of cash runway if free cash flow continues to grow at historical rates of 15.1% each year.


Next Steps

Dividend

What is Titan Medical's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate Titan Medical's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate Titan Medical's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as Titan Medical has not reported any payouts.

Unable to verify if Titan Medical's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as Titan Medical has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of Titan Medical's salary, the management and board of directors tenure and is there insider trading?

2.0yrs

Average management tenure


CEO

David McNally (57yo)

2.7yrs

Tenure

US$889,334

Compensation

Mr. David J. McNally has been Chief Executive Officer at Titan Medical Inc. since January 3, 2017 and has been its President since January 9, 2017. Mr. McNally was founder of Domain Surgical, Inc. and serv ...


CEO Compensation Analysis

David's remuneration is higher than average for companies of similar size in United States of America.

David's compensation has been consistent with company performance over the past year, both up more than 20%.


Management Age and Tenure

2.0yrs

Average Tenure

The tenure for the Titan Medical management team is about average.


Board Age and Tenure

2.3yrs

Average Tenure

64yo

Average Age

The average tenure for the Titan Medical board of directors is less than 3 years, this suggests a new board.


Insider Trading

No 3 month open market individual insider trading information.


Recent Insider Transactions

BuyUS$4,59022 Mar 19
Stephen Randall
EntityIndividual
Role
Member of the Board of Directors
CFO, Secretary & Director
Shares1,350
Max PriceUS$3.40
BuyUS$4,29319 Feb 19
John Barker
EntityIndividual
Role
Member of the Board of Directors
Director
Shares1,000
Max PriceUS$4.29
BuyUS$10,27422 Dec 18
John Barker
EntityIndividual
Role
Member of the Board of Directors
Director
Shares8,000
Max PriceUS$1.43
BuyUS$4,98422 Dec 18
Stephen Randall
EntityIndividual
Role
Member of the Board of Directors
CFO, Secretary & Director
Shares3,400
Max PriceUS$1.47

Ownership Breakdown


Management Team

  • David McNally (57yo)

    President

    • Tenure: 2.7yrs
    • Compensation: US$889.33k
  • Perry Genova

    Senior Vice President of Research & Development

    • Tenure: 2yrs
    • Compensation: US$672.60k
  • Stephen Randall

    CFO, Secretary & Director

    • Tenure: 1.8yrs
    • Compensation: US$565.06k
  • Bruce Wolff

    Senior Advisor & Member of Surgeon Advisory Board

    • Tenure: 0.3yrs
    • Compensation: US$83.12k
  • Chad Zaring

    Chief Commercial Officer

    • Tenure: 0.2yrs
  • Sachin Sankholkar

    Vice President of Marketing

    • Tenure: 0yrs
    • Compensation: US$440.77k

Board Members

  • Charlie Federico (70yo)

    Chairman of the Board

    • Tenure: 0.3yrs
  • David McNally (57yo)

    President

    • Tenure: 2.7yrs
    • Compensation: US$889.33k
  • John Barker (72yo)

    Director

    • Tenure: 10.3yrs
    • Compensation: US$76.07k
  • Dom Serafino (58yo)

    Director

    • Tenure: 1.3yrs
    • Compensation: US$75.60k
  • Lee Swanstrom

    Member of Surgeon Advisory Board

    • Tenure: 0yrs
  • John Schellhorn

    Independent Director

    • Tenure: 1.8yrs
    • Compensation: US$72.80k
  • Stephen Randall

    CFO, Secretary & Director

    • Tenure: 1.8yrs
    • Compensation: US$565.06k
  • John Valvo

    Member of Surgeon Advisory Board

    • Tenure: 9.1yrs
  • Arnold Advincula

    Member of Surgeon Advisory Board

    • Tenure: 5.7yrs
  • Eduardo Parra-Davila

    Member of Surgeon Advisory Board

    • Tenure: 0yrs

Company Information

Titan Medical Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Titan Medical Inc.
  • Ticker: TMDI
  • Exchange: NasdaqCM
  • Founded:
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: CA$86.909m
  • Listing Market Cap: CA$65.487m
  • Shares outstanding: 31.15m
  • Website: https://www.titanmedicalinc.com

Number of Employees


Location

  • Titan Medical Inc.
  • 170 University Avenue
  • Suite 1000
  • Toronto
  • Ontario
  • M5H 3B3
  • Canada

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
TMDTSX (The Toronto Stock Exchange)YesCommon SharesCACADJul 2008
TMDINasdaqCM (Nasdaq Capital Market)YesCommon SharesUSUSDJul 2008
QTNADB (Deutsche Boerse AG)YesCommon SharesDEEURJul 2008

Biography

Titan Medical Inc., a research and development stage company, focuses on the design, development, and commercialization of computer-assisted robotic surgical technologies for application in minimally invas ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/19 00:18
End of Day Share Price2019/09/18 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.